Docusign, Inc. filings document the public-company record for a cloud software business built around Intelligent Agreement Management, e-signature and contract lifecycle management. Its 8-K reports cover operating results, financial-condition updates, share repurchase authorization disclosures and material governance events, including appointments to the board of directors and related independence determinations.
Proxy materials provide formal disclosure on board structure, director matters, executive compensation, equity awards and stockholder meeting governance. Together, the filings describe Docusign’s reporting obligations, capital-return actions, governance framework and compensation practices alongside the operating performance of its agreement-management software business.
Trollope Rowan M reported acquisition or exercise transactions in this Form 4 filing.
DOCUSIGN, INC. director Rowan M. Trollope received a grant of 10,438 restricted stock units on May 8, 2026. Each RSU represents a contingent right to receive one share of DocuSign common stock.
The 10,438 RSUs will vest in twelve equal quarterly installments over three years, starting on May 2, 2026, as long as Trollope remains a service provider through each vesting date. The RSUs do not expire; they either vest into common shares or are canceled before vesting.
DOCUSIGN, INC. director Rowan M. Trollope has filed an initial Form 3, which is a required statement of beneficial ownership for insiders. This filing lists him as a director but does not report any stock transactions or derivative holdings in the provided data.
Docusign, Inc. appointed Rowan Trollope to its board of directors as an independent Class III director, effective May 2, 2026. His term runs until the 2027 Annual Meeting of Stockholders and continues until a successor is elected and qualified or earlier departure.
Trollope is currently CEO and a board member of database services company Redis, Inc., and previously served as CEO and director of Five9, Inc. and in senior leadership roles at Cisco. He will receive standard board compensation under Docusign’s existing director program and enter into the company’s standard indemnity agreement. A press release dated May 6, 2026, announces his appointment.
Docusign Inc reports a passive >5% stake held by Vanguard Capital Management as of 03/31/2026. Vanguard Capital Management reports beneficial ownership of 10,756,040 shares, representing 5.53% of common stock and discloses sole dispositive power over 10,756,040 shares and sole voting power over 1,800,826 shares. The filing is a Schedule 13G signed on 04/29/2026.
Docusign Inc shows a 5.85% passive stake held by Vanguard Portfolio Management. Vanguard Portfolio Management reports beneficial ownership of 11,385,156 shares of Docusign common stock with sole dispositive power over those shares and sole voting power for 97,858 shares. The filing is a Schedule 13G signed 04/29/2026.
BlackRock, Inc. filed Amendment No. 2 reporting beneficial ownership of 20,722,495 shares of DocuSign common stock, representing 10.7% of the class. The filing attributes holdings to certain "Reporting Business Units" of BlackRock and shows sole voting power of 19,845,918 shares.
Docusign, Inc. has issued its 2026 proxy statement outlining proposals for its virtual annual meeting and reporting fiscal 2026 performance. Stockholders will vote on electing three directors, ratifying PricewaterhouseCoopers as auditor, approving executive pay, setting Say‑on‑Pay frequency, and a stockholder compensation‑metrics proposal.
The Board highlights governance changes, including rotating the Board Chair role to James Beer, refreshing committee leadership, adding independent directors Mike Rosenbaum and Brian Roberts, and planning to seek stockholder approval in 2027 to declassify the Board. The company reports fiscal 2026 revenue of $3.2 billion, annual recurring revenue of $3,272 million, GAAP gross margin of 79.4%, and non‑GAAP diluted EPS of $3.84, with customers exceeding 1.8 million.
DOCUSIGN, INC. director Mary Agnes Wilderotter exercised stock options and sold shares in a routine transaction. She exercised options for 3,000 shares of Common Stock at an exercise price of $17.66 per share, then sold 3,000 shares at $48.15 per share on the same date.
After these transactions, she directly held 59,803 shares of DocuSign common stock. The derivative position tied to this specific option grant was fully exercised, with no remaining options from this grant shown in the filing.
DOCUSIGN, INC. Chief Revenue Officer Paula Hansen reported open-market sales of 6,000 shares of common stock on April 1, 2026. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, with sale prices ranging from about $45.85 to $48.00 per share. Following these sales, Hansen directly holds 79,233 shares of DocuSign common stock, indicating she retained a substantial equity position after the trades.